<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Genes &amp; Cells</journal-id><journal-title-group><journal-title xml:lang="en">Genes &amp; Cells</journal-title><trans-title-group xml:lang="ru"><trans-title>Гены и Клетки</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Genes and Cells</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-1829</issn><issn publication-format="electronic">2500-2562</issn><publisher><publisher-name xml:lang="en">Human Stem Cells Institute</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">121587</article-id><article-id pub-id-type="doi">10.23868/gc121587</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Antitumor RNase (binase) induces the alteration of cellular permeability</article-title><trans-title-group xml:lang="ru"><trans-title>РНКаза с противоопухолевым действием (биназа)вызывает изменение клеточной проницаемости</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Cabrera-Fuentes</surname><given-names>H A</given-names></name><name xml:lang="ru"><surname>Кабрера-Фуентес</surname><given-names>Э А</given-names></name></name-alternatives><bio xml:lang="en"><p>Kazan (Volga-Region) Federal University, Kazan</p></bio><bio xml:lang="ru"><p>Казанский (Приволжский) Федеральный университет, Казань</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Zelenikhin,</surname><given-names>P V</given-names></name><name xml:lang="ru"><surname>Зеленихин</surname><given-names>П В</given-names></name></name-alternatives><bio xml:lang="en"><p>Kazan (Volga-Region) Federal University, Kazan</p></bio><bio xml:lang="ru"><p>Казанский (Приволжский) Федеральный университет, Казань</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kolpakov,</surname><given-names>A I</given-names></name><name xml:lang="ru"><surname>Колпаков</surname><given-names>А И</given-names></name></name-alternatives><bio xml:lang="en"><p>Kazan (Volga-Region) Federal University, Kazan</p></bio><bio xml:lang="ru"><p>Казанский (Приволжский) Федеральный университет, Казань</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ilinskaya</surname><given-names>O N</given-names></name><name xml:lang="ru"><surname>Ильинская</surname><given-names>О Н</given-names></name></name-alternatives><bio xml:lang="en"><p>Kazan (Volga-Region) Federal University, Kazan</p></bio><bio xml:lang="ru"><p>Казанский (Приволжский) Федеральный университет, Казань</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Kazan (Volga-Region) Federal University, Kazan</institution></aff><aff><institution xml:lang="ru">Казанский (Приволжский) Федеральный университет, Казань</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2012-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2012</year></pub-date><volume>7</volume><issue>3</issue><issue-title xml:lang="en">NO3 (2012)</issue-title><issue-title xml:lang="ru">№3 (2012)</issue-title><fpage>72</fpage><lpage>76</lpage><history><date date-type="received" iso-8601-date="2023-01-11"><day>11</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2012, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2012, Эко-Вектор</copyright-statement><copyright-year>2012</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://genescells.ru/2313-1829/article/view/121587">https://genescells.ru/2313-1829/article/view/121587</self-uri><abstract xml:lang="en"><p>Some RNases including ones of microbial origin possess
antitumor activity, which mechanisms remains unclear. Here
we investigated the first step of RNase action towards
eukaryotic cells which is connected with increase of cell
permeability for ions and macromolecules.
Using radiological analysis of 45Са2+uptake by Candida
yeast and fluorescence imaging of human embryo kidney
cells HEK stained by Ca2+-specific Fura-2/АМ day the level
of intracellular Ca2+ under treatment with the RNase of
Bacillus intermedius (binase) was studied. Viability of lung
carcinoma epithelial cells A549 treated by binase was
measured by WST proliferation kit, stability of erythrocytes
was tested by lysis assay.
We have shown that binase induces the permeability
increase of lower and higher eukaryotic cells for Ca2+as
well as the increase of protein permeability of A549 cells.
Binase treatment protects erythrocytes from osmotic
shock.
The protective or cytotoxic binase effect followed by
increase of cellular permeability is realized depending on the
dell type, where the expression of КСa channels and of certain
oncogens, particularly of ras family, is crucial. The obtained
data supports the significance of the cell permeability increase
as a primary step in the mechanisms of binase-induced
biological effects.</p></abstract><trans-abstract xml:lang="ru"><p>Ряд РНКаз, среди которых есть и микробные ферменты, обладает протовоопухолевым действием, механизм которого не ясен. В настоящей работе исследован начальный
этап взаимодействия РНКаз с эукариотическими клетками,
связанный с изменением их проницаемости для ионов и
макромолекул.
На клеточных культурах карциномы легких А549, эмбриональной почки человека НЕK и дрожжах Candida с
использованием анализа поглощения изотопа 45Са2+ либо
флуоресцентного красителя Fura-2/АМ изучено влияние
цитотоксичной РНКазы Bacillus intermedius (биназы) на
накопление внутриклеточного кальция. Изменение проницаемости клеток А549, обработанных биназой, проанализировано по проникновению меченого трипановым синим
альбумина через клеточный монослой. Выживаемость
клеток А549 оценена по активности митохондриальных дегидрогеназ, восстанавливающих производные тетразолия,
стабильность мембран эритроцитов оценена по выходу гемоглобина при осмотическом шоке.
Установлено, что биназа увеличивает проницаемость
клеток высших и низших эукариот для ионов кальция. Клетки А549 под действием биназы также усиливают прони-
цаемость для макромолекул. Обработка биназой защищает
эритроциты от осмотического шока.
Следующее за увеличением проницаемости протекторное либо цитотоксическое действие биназы реализуется
в зависимости от типа клеток, где ключевую роль играет экспрессия КСa каналов и определенных онкогенов, в
частности, онкогенов семейства ras. Полученные данные
подтверждают принципиальную важность увеличения клеточной проницаемости как первичного этапа в механизме
проявления биологических эффектов биназы.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Binase</kwd><kwd>cytotoxicity</kwd><kwd>cellular permeability</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Биназа</kwd><kwd>цитотоксичность</kwd><kwd>проницаемость клеток</kwd><kwd>Са2+</kwd><kwd>Са2+</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Spalletti-Cernia D., Sorrentino R., Di Gaetano S. et al. Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis. J. Clin. Endocrinol. Metab. 2003; 88(6): 2900-7.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Makarov A.A., Kolchinsky A., Ilinskaya O.N. Binase and other microbial RNases as potential anticancer agents. BioEssays 2008; 30: 781-90.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Lee J.E., Raines R.T. Ribonucleases as novel chemotherapeutics: the ranpirnase example. BioDrugs 2008; 22(1): 53-8.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Ardelt W., Shogen K., Darzynkiewicz Z. Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes. Curr. Pharm. Biotechnol. 2008; 9(3): 215-25.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Sevcik J., Urbanikova L., Leland P.A. et al. X-ray structure of two crystalline forms of a streptomycete ribonuclease with cytotoxic activity. J. Biol. Chem. 2002; 277(49): 47325-30.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Ilinskaya O.N. Dreyer F., Mitkevich V.A. et al. Changing the net charge from negative to positive makes ribonuclease Sa cytotoxic. Protein Sci. 2002; 11(10): 2522-25.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Makarov A.A., Ilinskaya O.N. Cytotoxic ribonucleases: molecular weapons and their targets. FEBS Lett. 2003; 540(1-3): 15-20.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Ilinskaya O., Decker K., Koschinski A. et al. Bacillus intermedius ribonuclease as inhibitor of cell proliferation and membrane current. Toxicology 2001; 156(2-3): 101-7.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Mitkevich V.A., Petrushanko I.Y., Kretova O.V. et al. Oncogenic c-kit transcript is a target for binase. Cell Cycle 2010; 9(13): 2674-8.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Mitkevich V.A., Petrushanko I.Y., Spirin P.V. et al. Sensitivity of acute myeloid leukemia Kasumi-1 cells to binase toxic action depends on the expression of KIT and АML1-ETO oncogenes. Cell Cycle 2011; 10(23): 4090-97.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Ilinskaya O.N., Koschinski A., Repp H. et al. RNase induced apoptosis: fate of calcium-activated potassium channels. Biochemie 2008; 90(5): 717-25.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Zhao H., Ardelt B., Ardelt W. et al. The cytotoxic ribonuclease onconase targets RNA interference (siRNA). Cell Cycle 2008; 7(20): 3258-61.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Bracale A., Spalletti-Cernia D., Mastronicola M. et al. Essential stations in the intracellular pathway of cytotoxic bovine seminal ribonuclease. Biochem. 2002; 362(Pt 3): 553-60.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Navarro S., Aleu J., Jiménez M. et al. The cytotoxicity of eosinophil cationic protein/ribonuclease 3 on eukaryotic cell lines takes place through its aggregation on the cell membrane. Cell Mol. Life Sci. 2008; 65(2): 324-37.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Кабрера-Фуентес Э.А., Калачева Н.В., Мухаметшина Р.Т. и др. Проникновение биназы в клетки альвеолярного эпителия не индуцирует их гибель. Биомед. Хим. 2012; 58(3): 272-80.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Schulga A., Kurbanov F., Kirpichnikov M. et al. Comparative study of binase and barnase: experience in chimeric ribonucleases. Protein Eng. 1998; 11(9): 773-80.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Yakovlev G.I., Moiseyev G.P., Struminskaya N.K. et al. Mutational analysis of the active site of RNase of Bacillus intermedius (BINASE). FEBS Lett. 1994; 354 (3): 305-6.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Ilinskaya O.N., Ivanchenko O.B., Karamova N.S. et al. SOSinducing ability of native and mutant microbial ribonucleases. Mut. Res. 1996; 354(2): 203-9.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Noll T., Wozniak G., McCarson K. et al. Effect of factor XIII on endothelial barrier function. J. Exp. Med. 1999; 189(3): 1373-82.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Kolpakov A.I., Kupriianova F.G. Effect of exogenous ribonucleases on the propagation of Candida tropicalis yeast. Mikrobiologiia 1992; 61(6): 969-74.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Porta C., Paglino C., Mutti L. Ranpirnase and its potential for the treatment of unresectable malignant mesothelioma. Biologics 2008; 2(4): 601-9.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Ilinskaya O.N., Koschinski A., Mitkevich V.A. et al. Cytotoxicity of RNases is increased by cationization and counteracted by Kca channels. BBRC 2004; 314: 550-54.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Hollenhorst M.I., Richter K., Fronius M. Ion transport by pulmonary epithelia. J. Biomed. Biotechnol. 2011. Epub. 2011 Oct 27.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Rodenhuis S., van de Wetering M.L, Mooi W.J. et al. Mutational activation of the K-ras oncogene: a possible pathogenetic factor in adenocarcinoma of the lung. N. Engl. J. Med. 1987; 317(15): 929-35.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Xiao G.C., Otani S., Yan L. et al. Inhibition of Farnesyl Protein Transferase, H-ras Oncogene Expression and P21ras Membrane Association by Natural Products in Human Solid Tumor Cell Lines. J. Asian Nat. Prod. Res. 1998; 1: 29-51.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Lang F., Birka C., Myssina S. et al. Erythrocyte ion channels in regulation of apoptosis. Adv. Exp. Med. Biol. 2004; 559: 211-7.</mixed-citation></ref></ref-list></back></article>
